<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SEC Registration Archives - Quantum Accounting Inc.</title>
	<atom:link href="https://quantum.accountants/en/category/sec-registration/feed/" rel="self" type="application/rss+xml" />
	<link>https://quantum.accountants/en/category/sec-registration/</link>
	<description>新しい時代の財務会計課題に「第三の参謀」を</description>
	<lastBuildDate>Fri, 14 Nov 2025 06:31:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://quantum.accountants/wp-content/uploads/2025/10/cropped-QA-mark-32x32.png</url>
	<title>SEC Registration Archives - Quantum Accounting Inc.</title>
	<link>https://quantum.accountants/en/category/sec-registration/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Interview with SAWAI GROUP HOLDINGS Co., Ltd. ~The Background of the Holding Company Transition and the Practice of SEC Registration~</title>
		<link>https://quantum.accountants/en/interview-with-sawai-group-holdings-co-ltd-the-background-of-the-holding-company-transition-and-the-practice-of-sec-registration/</link>
		
		<dc:creator><![CDATA[Accounting Monster]]></dc:creator>
		<pubDate>Wed, 28 Sep 2022 03:00:08 +0000</pubDate>
				<category><![CDATA[SEC Registration]]></category>
		<guid isPermaLink="false">https://quantum.accountants/?p=32817</guid>

					<description><![CDATA[<p>Please note that the original article is in Japanese. The following is a summary of its content. The Trigger for SEC Registration On April 1, 2021, Sawai Pharmaceutical Co., Ltd. (Sawai Pharmaceutical), a company well-known for generic drugs, transitioned to a holding company structure by establishing SAWAI GROUP HOLDINGS Co., Ltd. as its new parent ...</p>
<p>The post <a href="https://quantum.accountants/en/interview-with-sawai-group-holdings-co-ltd-the-background-of-the-holding-company-transition-and-the-practice-of-sec-registration/">Interview with SAWAI GROUP HOLDINGS Co., Ltd. ~The Background of the Holding Company Transition and the Practice of SEC Registration~</a> appeared first on <a href="https://quantum.accountants/en/">Quantum Accounting Inc.</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>SEC proposed changes to Regulation S-K</title>
		<link>https://quantum.accountants/en/sec-regulation-s-k-2/</link>
		
		<dc:creator><![CDATA[Masato Minamizuka]]></dc:creator>
		<pubDate>Fri, 01 Dec 2017 07:29:34 +0000</pubDate>
				<category><![CDATA[SEC Registration]]></category>
		<category><![CDATA[US GAAP]]></category>
		<guid isPermaLink="false">http://quantum.accountants/?p=584</guid>

					<description><![CDATA[<p>SEC proposed changes to Regulation S-K Summarized to the Bits SEC issued proposed changes to Regulation S-K. This proposal does not change significantly the current disclosure requirement, however, this revision of Regulation S-K includes a number of minor revisions and thus it is the most extensive revision in 30 years since its issuance. It seems ...</p>
<p>The post <a href="https://quantum.accountants/en/sec-regulation-s-k-2/">SEC proposed changes to Regulation S-K</a> appeared first on <a href="https://quantum.accountants/en/">Quantum Accounting Inc.</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
